Crude-Lysate PCR Composition with Inhibitor Blocking and Antifoam
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing PCR methods struggle with reliable amplification and detection of low copy number nucleic acids, especially in crude or unpurified samples, due to the presence of inhibitors and foaming issues.
Innovation Solution
A PCR composition comprising a thermostable DNA polymerase, antifoam agent, dNTP and dNTP derivative, and PCR inhibitor blocking agents, optimized for use with crude lysates, to enhance amplification and detection of nucleic acids.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If PCR is performed on crude lysate samples, then the method can detect low copy number nucleic acids directly without purification, but the presence of inhibitors in the crude sample reduces amplification reliability
Solution Approach 1:
The patent introduces specific intermediary substances (inhibitor blocking agents, antifoam agents, and optimized buffer components) that mediate between the crude sample and the PCR reaction. These intermediaries bind to or neutralize inhibitors in the crude lysate, allowing the PCR reaction to proceed reliably without requiring extensive sample purification, thus maintaining both operational simplicity and amplification reliability
Solution Approach 2:
The patent optimizes multiple reaction parameters including salt concentrations (NaCl, KCl, MgCl2), dNTP concentrations, and polymerase amounts to create a reaction environment that is tolerant of crude sample inhibitors. By adjusting these parameters, the system achieves reliable amplification from crude lysates while maintaining ease of operation
2Device complexity
If standard PCR composition is used, then the reaction can proceed with simple components, but foaming occurs during thermal cycling which reduces detection accuracy
Solution Approach 1:
The patent introduces antifoam agents as intermediary substances that specifically address the foaming problem during thermal cycling. These agents reduce surface tension and prevent foam formation without interfering with the PCR reaction or detection processes, thereby maintaining composition simplicity while improving detection accuracy
Solution Approach 2:
The patent modifies the composition by adding specific substances (antifoam agents, detergent alternatives) and optimizing concentrations of existing components to prevent foaming during thermal cycling, thus maintaining simple composition while improving measurement precision
3Measurement precision
If PCR is performed with low copy number targets, then the method can detect rare nucleic acid sequences, but the amplification efficiency decreases and requires longer run times
Solution Approach 1:
The patent optimizes multiple parameters including increasing polymerase amount, optimizing dNTP concentrations, adjusting salt concentrations, and modifying thermal cycling conditions to enhance amplification efficiency for low copy number targets, thereby improving both detection sensitivity and amplification speed
Solution Approach 2:
The patent uses a composite reaction composition combining multiple optimized components (specific polymerases, buffer systems, inhibitor blockers, antifoam agents) that work synergistically to improve amplification efficiency for low copy number targets, achieving both high sensitivity and reasonable run times
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition achieves superior amplification, detection, and quantitation of nucleic acids in crude samples, with improved sensitivity, specificity, and reduced run time compared to standard PCR methods.
Implementation Method 1
polymerase chain reaction (PCR) is an in vitro method for the enzymatic synthesis of specific DNA sequences
Implementation Method 2
enzymatic synthesis of specific DNA sequences using two oligonucleotide primers
Implementation Method 3
an antifoam agent is present
Implementation Method 4
at least two PCR inhibitor blocking agents
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Compositions, methods, and kits for synthesizing, detecting, and/or quantifying nucleic acids are provided herein. Embodiments comprise a nucleic acid amplification composition comprising a thermostable DNA polymerase and agents which improve nucleic acid synthesis, amplification, detection, and/or quantification of nucleic acid targets in a crude extract or crude lysate sample.